Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2026 18:15 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Eos Energy Enterprises (EOSE) Faces Securities Class Action Amid Analyst Questions Over Management’s Transparency, Shares Crater 39% -- Hagens Berman

Investors who lost money in EOSE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
02. April 2026 13:19 ET | Quelle: Glancy Prongay Wolke & Rotter LLP

Deadline Alert: Power Solutions International, Inc. (PSIX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 19, 2026 deadline to file a lead plaintiff motion in the class action...
02. April 2026 12:39 ET | Quelle: World Vapers’ Alliance

Cherry-Picking Science: WVA Condemns EU Tobacco Report

BRUSSELS, April 02, 2026 (GLOBE NEWSWIRE) -- The European Commission’s newly released evaluation of the Tobacco Products Directive (TPD) is facing sharp criticism from the World Vapers’ Alliance...
02. April 2026 12:00 ET | Quelle: Regeneron Pharmaceuticals, Inc.

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing...
02. April 2026 11:26 ET | Quelle: Momentum Cyber Group LLC

Cybersecurity Financing Surges 33% Year-Over-Year to $3.8B in Q1 2026

AUSTIN, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Momentum Cyber, the only investment bank exclusively focused on cybersecurity, today released its Q1 2026 Cybersecurity Market Review. The report...
02. April 2026 09:00 ET | Quelle: Portnoy Law

HelloFresh SE Investigated by the Portnoy Law Firm

LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HelloFresh SE, (“HelloFresh" or the "Company") (OTCMKTS:HELFY) investors that the firm has initiated an investigation...
02. April 2026 09:00 ET | Quelle: Portnoy Law

America’s Car-Mart, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises America’s Car-Mart, Inc., (“Car-Mart" or the "Company") (NASDAQ:CRMT) investors that the firm has initiated an...
02. April 2026 09:00 ET | Quelle: Portnoy Law

America’s Car-Mart, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises America’s Car-Mart, Inc., (“Car-Mart" or the "Company") (NASDAQ:CRMT) investors that the firm has initiated an...
02. April 2026 07:01 ET | Quelle: Adagene Inc.

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patients with and without liver metastases Study will be sponsored and conducted by Incyte; Adagene to provide...
02. April 2026 07:00 ET | Quelle: Adagene Inc.

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

Dose-Dependent Efficacy Results: As of the latest data cut, muzastotug achieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement...

Nächste Seite